INDUSTRY

Healthcare / Pharmaceutical Productions
SERVICES: Custom Software Development, Industrial Integrations, Regulatory Compliance
CHALLENGE
Laboratorios Asserca invested in a state-of-the-art facility for the production of parenteral nutrition (intravenous admixtures) for neonatal, pediatric, and adult patients. To support this investment, the project required software solutions capable of addressing critical challenges:
​
Digital regulatory compliance: ensuring traceability and adherence to ANMAT–INAME regulations, including official authorization (DI-2025-143-APN-ANMAT#MS), through systems that support audits and automated reporting.
​
Automation of critical processes: implementing software to control formulation and dosing in real time, integrated with mixing and filtration hardware to guarantee sterile conditions.
​
Integration of medical and production workflows: connecting medical prescriptions with a production platform through a secure digital system, eliminating manual errors and ensuring accuracy, safety, and scalability.
SOLUTION
DAAS designed and implemented an integrated digital system tailored to Asserca’s industrial and regulatory needs:
​
Production Management Platform: automated formulation adapted to patient needs, integrated with dosing and mixing hardware, ensuring real-time quality control.
​
Digital Prescription Module: physicians generate prescriptions directly connected to the production system, eliminating manual errors.
​
Kanban Dashboard & Traceability: complete management of production and lifecycle, from raw materials to final labeled bags, fully compliant with ANMAT standards.
​
Audit & Monitoring Tools: observability modules that ensure regulated workflows.
​
Backoffice: stock management, compatibility/stability validation, and automated regulatory reporting.
IMPACT
With DAAS solutions, Asserca achieved:
​
Regulatory certification and official authorization to operate as a parenteral nutrition manufacturer in Argentina.
​
Greater reliability and patient safety, reducing microbiological risks and ensuring full traceability.
​
Improved operational efficiency, reducing formulation times and increasing productivity.
​
The ability to deliver personalized formulations instead of relying on generic admixtures.
​
Strengthened credibility among leading healthcare institutions such as Hospital Elizalde, Hospital Garrahan, Hospital Sarda, and Fundación Favaloro.

